158
Participants
Start Date
March 29, 2017
Primary Completion Date
April 25, 2019
Study Completion Date
April 25, 2019
AR-105
monoclonal antibody
Placebo
matching placebo (+ SOC antibiotics)
Research Site 3, Taipei
Research Site, Brussels
Research Site 3, Budapest
Research Site, Brussels
Research Site, Liège
Research Site 1, Kutaisi
Research Site 2, Kutaisi
Research Site, Adelaide
Research Site, Dinant
Research Site, Yvoir
Research Site, Prague
Research Site 4, Taipei
Research Site 1, Athens
Research Site, Brussels
Research Site 2, Taipei
Research Site 2, Athens
Research Site, Prague
Research Site, Lima
Research Site, Miraflores
Research Site, San Martín de Porres
Research Site, Prague
Research Site, Wŏnju
Research Site, Durham
Research Site, Madrid
Research Site, Pilsen
Research Site 3, Jacksonville
Research Site, Oviedo
Research Site 4, Tampa
Research Site, Tours
Research Site, Santander
Research Site 2, Taichung
Research Site 6, Lexington
Research Site 1, Taichung
Research Site 1, Larissa
Research Site 2, Larissa
Research Site, Teplice
Research Site, Tarragona
Research Site, Columbus
Research Site, Nantes
Research Site 1, Guadalajara
Research Site 2, Guadalajara
Research Site 9, Royal Oak
Research Site 7, Detroit
Research Site 8, Detroit
Research Site, Angers
Research Site, Lille
Research Site, Tourcoing
Research Site 5, Chicago
Research Site 10, St Louis
Research Site, St Louis
Research Site, Monterrey
Research Site, Brno
Research Site, Strasbourg
Research Site, Lyon
Research Site, Pierre-Bénite
Research Site, Lyon
Research Site, Tainan City
Research Site 1, Paris
Research Site 2, Paris
Research Site, Paris
Research Site, Ivano-Frankivsk
Research Site, Zlín
Research Site, Le Chesnay
Research Site, Lviv
Research Site 1, Kaohsiung City
Research Site 2, Kaohsiung City
Research Site, La Roche-sur-Yon
Research Site, Limoges
Research Site 2, San Diego
Research Site, Colombes
Research Site, Argenteuil
Research Site, Pontoise
Research Site 1, Sacramento
Research Site 2, Novosibirsk
Research Site 2, Saint Petersburg
Research Site 3, Saint Petersburg
Research Site 4, Saint Petersburg
Research Site 1, Saint Petersburg
Research Site, Vitebsk
Research Site, Minsk
Research Site, Minsk
Research Site, Brest
Research Site, Grodno
Research Site, Homyel
Research Site, Krasnodar
Research Site 3, Novosibirsk
Research Site 1, Novosibirsk
Research Site, Tomsk
Research Site, Krasnoyarsk
Research Site, Hackensack
Research Site, Woolloongabba
Research Site, Tbilisi
Research Site 2, Budapest
Research Site 1, Budapest
Research Site, Debrecen
Research Site, Nyíregyháza
Research Site, Opole
Research Site, Warsaw
Research Site 1, Gyeonggi-do
Research Site 2, Gyeonggi-do
Research Site 2, Seoul
Research Site 1, Seoul
Research Site 3, Seoul
Research Site 4, Seoul
Research Site 1, Barcelona
Research Site 2, Barcelona
Research Site 3, Barcelona
Research Site 4, Barcelona
Research Site, Mataró
Research Site 1, Taipei
Research Site, Kiev
Lead Sponsor
Aridis Pharmaceuticals, Inc.
INDUSTRY